These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10358225)

  • 1. Effect of phenolic and chlorine disinfectants on hepatitis C virus binding and infectivity.
    Agolini G; Russo A; Clementi M
    Am J Infect Control; 1999 Jun; 27(3):236-9. PubMed ID: 10358225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of disinfectant efficacy against hepatitis C virus using a RT-PCR-based method.
    Charrel RN; de Chesse R; Decaudin A; De Micco P; de Lamballerie X
    J Hosp Infect; 2001 Oct; 49(2):129-34. PubMed ID: 11567559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of the Poliovirus 1 genome by chlorine dioxide.
    Simonet J; Gantzer C
    J Appl Microbiol; 2006 Apr; 100(4):862-70. PubMed ID: 16553743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
    Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
    Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
    Hong HW; Lee SW; Myung H
    J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral mode of action of a synthetic brassinosteroid against Junin virus replication.
    Castilla V; Larzábal M; Sgalippa NA; Wachsman MB; Coto CE
    Antiviral Res; 2005 Nov; 68(2):88-95. PubMed ID: 16171877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
    Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
    Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative real-time RT-PCR to study hepatitis C virus binding onto mammalian cells.
    Germi R; Crance JM; Garin D; Guimet J; Zarski JP; Drouet E
    Am Clin Lab; 2001 Aug; 20(7):26-8. PubMed ID: 11570271
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on inactivation kinetics of hepatitis A virus and enteroviruses with peracetic acid and chlorine. New ICC/PCR method to assess disinfection effectiveness.
    Bigliardi L; Sansebastiano G
    J Prev Med Hyg; 2006 Jun; 47(2):56-63. PubMed ID: 17066904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
    Jia YT; Wei L; Jiang D; Cong X; Fei R
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of methods for hepatitis C virus inactivation.
    Pfaender S; Brinkmann J; Todt D; Riebesehl N; Steinmann J; Steinmann J; Pietschmann T; Steinmann E
    Appl Environ Microbiol; 2015 Mar; 81(5):1616-21. PubMed ID: 25527548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus.
    Lee JH; Teuber G; von Wagner M; Roth WK; Zeuzem S
    J Med Virol; 2000 Mar; 60(3):264-8. PubMed ID: 10630957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system.
    Bourne N; Pyles RB; Yi M; Veselenak RL; Davis MM; Lemon SM
    Antiviral Res; 2005 Aug; 67(2):76-82. PubMed ID: 15927278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
    Ikeda M; Abe K; Yamada M; Dansako H; Naka K; Kato N
    Hepatology; 2006 Jul; 44(1):117-25. PubMed ID: 16799963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
    Ikeda M; Mori K; Ariumi Y; Dansako H; Kato N
    FEBS Lett; 2009 May; 583(9):1434-8. PubMed ID: 19332062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon].
    Jia YT; Wei L; Jiang D; Cong X; Fei R
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.